1. Immunology/Inflammation Apoptosis
  2. STING Cyclic GMP-AMP Synthase IFNAR TNF Receptor Interleukin Related
  3. STING agonist-45

STING agonist-45 是一种选择性的 STING 激动剂 (EC50 = 0.28 μM)。STING agonist-45 通过 cGAS-STING 通路激活先天免疫反应,上调 p-TBK1 和 IRF3 等关键标志物。STING agonist-45 在人外周血单核细胞 (PBMC) 中表现出强大的 STING 激活作用,诱导 I 型干扰素 (如IFN-β) 以及下游细胞因子 (如TNF-α和IL-6) 产生。STING agonist-45 在小鼠模型中增强抗肿瘤免疫力,抑制肿瘤生长,增加 CD8+ T 细胞浸润。STING agonist-45 可用于 STING 相关疾病研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

STING agonist-45

STING agonist-45 Chemical Structure

CAS No. : 2361424-97-5

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

STING agonist-45 is a selective STING agonist (EC50 = 0.28 μM). STING agonist-45 activates the innate immune response through the cGAS-STING pathway, upregulating key markers such as p-TBK1 and IRF3. STING agonist-45 exhibits robust STING activation in human peripheral blood mononuclear cells (PBMCs), inducing the production of type I interferons (such as IFN-β) and downstream cytokines (such as TNF-α and IL-6). STING agonist-45 enhances anti-tumor immunity, inhibits tumor growth, and increases CD8+ T cell infiltration in mouse models. STING agonist-45 is promising for the study of STING-related diseases[1][2].

体外研究
(In Vitro)

STING agonist-45 (Compound 12L) (24 小时) 在 RAW 264.7 细胞中诱导报告信号,EC50 值为 5.22 µM[1]
STING agonist-45 (24 小时) 对 THP1 细胞表现出明显的细胞毒性[1]
STING agonist-45 (24 小时) 可与各种 hSTING 等位基因 (IC50 = 8.97 µM) 和 mSTING (IC50 = 4.35 µM) 的羧基末端结构域 (CTD) 结合[1]
STING agonist-45 (Example 1) (24 小时) 刺激 THP1 细胞产生 CXCL10 (IP10) 细胞因子, EC50 值为 1.6 µM[2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

STING agonist-45 (Compound 12L) (3-30 mg/kg,静脉注射,每日一次,4 天) 在 C57BL/6 小鼠模型中诱导 IFN-β 蛋白[1]
STING agonist-45 (10 mg/kg,静脉注射,每日一次,7 天) 在 B16.F10 荷瘤 C57BL/6 小鼠模型中缩小肿瘤体积,延长生存时间[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 mice (6-8 weeks old) model[1]
Dosage: 3, 10, 30 mg/kg
Administration: i.v., once a day, 4 days
Result: Dose-dependent induced IFN-β protein.
Animal Model: B16.F10 tumor-bearing (105) C57BL/6 mice (6-8 weeks old) model[1]
Dosage: 10 mg/kg
Administration: i.v., once a day, 7 days
Result: Reduced tumor volume, prolonged the survival time.
分子量

426.47

Formula

C21H26N6O4

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
STING agonist-45
目录号:
HY-177338
需求量: